EDCTP: Targeting Control and Elimination of NIDs Through Clinical Trials, Oct 2017

EDCTP is launching 11 calls for proposals in 2017 to support clinical research and capacity building in sub-Saharan Africa. These calls represent a total investment of more than € 156.5M to tackle poverty-related diseases (PRDs), including neglected ones.

The purpose of the "Targeting control and elimination of NIDs through clinical trials" Call for Proposals is to provide funding for clinical trials to accelerate the development of new or improved therapeutics for NIDs in sub-Saharan Africa. Proposals must include one or more clinical trial(s) (phases I to III) conducted in sub-Saharan Africa to evaluate the safety and efficacy of new or improved drugs, drug regimens and formulations, including for prevention and post-exposure prophylaxis. 

EDCTP considers that proposals for activities of between 36 and 60 months duration and requesting funding of up to € 5 million would allow the specific challenges to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting another duration and/or funding.

Consortia comprising a minimum of three independent legal entities are eligible to apply. Two of the legal entities must be established in two different European Participating States(2) of the EDCTP Association and one of the legal entities must be established in a sub-Saharan African country(3). All three legal entities shall be independent of each other.

For the purpose of this call, NIDs include: Buruli ulcer, cysticercosis/taeniasis, dengue, dracunculiasis, echinococcosis, foodborne trematodiases, leprosy (Hansen disease), human African trypanosomiasis, leishmaniasis, lymphatic filariasis, mycetoma, onchocerciasis, rabies, schistosomiasis, soil-transmitted helminthiases, trachoma, yaws.

For the full call text please visit the EDCTP grant call webpage.